New studies in major depression find VNS improves the quality of life of patients with treatment-resistant depression and two other findings.
Test your knowledge on incidence of schizophrenia, risk factors associated with psychosis, gender and cultural distinctions, and more.
Our CME collection features innovative strategies for addressing SUDS, inflammation and schizophrenia, sexual dysfunction, restless legs syndrome, and more. All free, all the time.
A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.
A roundup on recent happenings from around the web include stories on the perils of job insecurity; depression and cardiac risks; the longest-running mental health study; smart drugs that aren’t so smart; heatstroke in psychiatric patients; an autism puzzler; and psychosis and eating disorders.
New research brings us closer to learning about the associations between psychological states, quality of life, and cardiovascular health.
New data indicate that dementia is largely undiagnosed or unrecognized; exposure to general anesthesia and surgery can lead to a subtle decline in memory and thinking skills in older adults; and sarcopenic obesity in older adults may predict dementia.
This special collection provides new insights on major aspects of depression: psychopharmacology, therapeutic interventions, major depressive episodes, biomarkers, and pseudobulbar affect.
A meta-analysis exploring factors associated with quality of life in first-episode psychosis provides guidance and take-home points for clinicians.
ECT is a highly effective treatment for depression, but a portion of patients fail to respond as hoped. Clinical variables have overall limited utility as a predictor of response. Is inflammation the key?